60583-39-3 Brucine sulfate heptahydrate AKSci W0016
 
 
Loading Please Wait...
  W0016    AKSci Bulk Reagent
Brucine sulfate heptahydrate
, 98% (HPLC)
 



IDENTITY
CAS Number:60583-39-3
MDL Number:MFCD00150159
MF:2C23H26N2O4.7H2O.H2O4S
MW:1013.11
EINECS:225-432-9
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:98% (HPLC)
Physical Form (at 20°C):Solid
Melting Point:180°C (dec.)
Optical Rotation:-24 ~ -27° (c=1 in H2O)
Long-Term Storage:Store long-term in a cool, dry place
DOT/IATA TRANSPORT INFORMATION
UN #:UN1544
Hazard Class:6.1; Poison
Packing Group:II
A hazmat fee may apply to certain package sizes. Please check pricing table for an indicator of applicable hazmat fees.

REVIEW

 Brucine is a bitter alkaloid, and an isomer of strychnine, though not poisonous.. It occurs in several plant species, the most well known being the Strychnos nux-vomica tree, found in South-East Asia. For medicinal purposes, brucine is primarily used in the regulation of high blood pressure and other comparatively benign cardiac ailments. Brucine also shows the pain modulation and anti-inflammation effects which are mediated by central and peripheral mechanisms. Brucine also has a long history of being used as a traditional medicine for the treatment of hepatocellular carcinoma) in China. Brucine downregulated expression levels of HIF-1 responsive genes in vivo which appear to be implicated in the anti-metastasis activity of brucine. In colon cancer, brucine could inhibit angiogenesis viathe KDR signaling pathway and be a useful therapeutic candidate for colon cancer intervention. In LoVo cells, , brucine caused G1-cell cycle arrest and apoptosis, possibly by inhibition of VEGFR2. Brucine has also been shown to induce apoptosis in U266 cells via the JNK signaling pathway and phosphorylation of c-Jun. Brucine can also cause apoptosis in A549 cells by inhibiting the activity of NF-kappaB and the subsequent COX-2 gene expression. In the cancer arena brucine appears to have a wide range of mechanistic activity. Brucine, which is basic, is frequently used as agents for chiral resolution of racemic acidic compounds, giving rise to the separation of racemic mixtures.

REFERENCES
[1]Bialonska, Agata; Ciunik, Zbigniew Dibrucinium sulfate heptahydrate. Acta Crystallographica, Section E: Structure Reports Online (2005), 61(12), 4222.
[2] Yin W, Wang TS, Yin FZ, Cai BC. Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica. J Ethnopharmacol. 2003 Oct;88(2-3):205-14.
[3] Yin W, Wang TS, Yin FZ, Cai BC. Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica. J Ethnopharmacol. 2003 Oct;88(2-3):205-14.
[4] Shu G, Mi X, Cai J, Zhang X, Yin W, Yang X, Li Y, Chen L, Deng X. Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: the role of hypoxia inducible factor 1 pathway Toxicol Lett. 2013 Oct 24;222(2):91-101.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Danger

Hazard Statements
H300+H330

Precautionary Statements
P260; P264; P270; P271; P284; P301+P310+P330; P304+P340+P310; P403+P233; P405; P501


Current as of April 19, 2024


Download SDS Request COA

All products are stocked and shipped from San Francisco Bay Area, California, USA.

⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.



CATEGORIES

 APIs and Bioactives > Alkaloids
 Chiral Synthesis >
 Chiral Synthesis >


PubChem
  @PubMed